COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders- updated guideline (NG167)

Recommendation 3.2 has been updated to highlight the possible risk of adrenal crisis for patients on long-term corticosteroids.

Source:

National Institute for Health and Care Excellence